Statement of Cash Flows	12 Months Ended
	Dec. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (1,113,238)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	128,160
Transaction costs incurred in connection with the initial public offering	210
Interest earned on marketable securities held in Trust Account	(102,287)
Unrealized loss on marketable securities held in Trust Account	49,459
Changes in operating assets and liabilities:
Prepaid expenses	(290,227)
Income Tax Payable
Related party payable	180,273
Accounts payable and accrued expenses	1,401,692
Net cash provided in operating activities	254,042
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(258,750,000)
Net cash used in investing activities	(258,750,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	253,680,505
Proceeds from sale of Private Placement Units	6,819,495
Proceeds from promissory note – related party	149,476
Repayment of promissory note – related party	(149,476)
Payment of offering costs	(502,651)
Net cash provided by financing activities	259,997,349
Net Change in Cash	1,501,391
Cash – Beginning of period
Cash – End of period	1,501,391
Non-Cash investing and financing activities:
Initial value of common stock subject to possible redemption	258,750,000
Issuance of Representative Shares	20
Deferred offering costs paid directly by Sponsor in exchange for the issuance of Class B common stock	25,000
Deferred offering costs in accrued expenses	$ 85,000